TNF and vascular disorder: Currently, a tailored treatment with anti-TNFα agents shows a crucial role in treating patients with a vasculopathy phenotype [1, 4, 5, 8, 9, 11, 12, 16, 17, 19–21, 23, 24, 28–32, 34–40, 43, 45, 46, 50, 53, 54, 56, 60–63, 65–67, 69, 71, 73–82, 85, 87, 89–91].